BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $320,802 | -23.4% | 13,340 | +1.7% | 0.00% | -100.0% |
| Q2 2023 | $418,704 | +1.2% | 13,112 | -3.0% | 0.00% | 0.0% |
| Q1 2023 | $413,557 | -25.6% | 13,521 | -5.1% | 0.00% | 0.0% |
| Q4 2022 | $555,826 | -0.9% | 14,242 | +20.7% | 0.00% | 0.0% |
| Q3 2022 | $561,000 | -2.9% | 11,799 | -20.8% | 0.00% | 0.0% |
| Q2 2022 | $578,000 | -29.8% | 14,889 | +2.9% | 0.00% | -50.0% |
| Q1 2022 | $823,000 | -27.7% | 14,471 | +1.4% | 0.00% | 0.0% |
| Q4 2021 | $1,139,000 | -32.9% | 14,272 | -26.9% | 0.00% | -50.0% |
| Q3 2021 | $1,697,000 | -23.3% | 19,519 | +14.1% | 0.00% | -20.0% |
| Q2 2021 | $2,213,000 | +113.0% | 17,106 | +31.6% | 0.01% | +150.0% |
| Q1 2021 | $1,039,000 | +44.9% | 12,998 | +47.9% | 0.00% | 0.0% |
| Q4 2020 | $717,000 | +217.3% | 8,786 | -4.2% | 0.00% | +100.0% |
| Q3 2020 | $226,000 | -10.7% | 9,175 | +1.7% | 0.00% | 0.0% |
| Q2 2020 | $253,000 | – | 9,025 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |